ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

MNPR Monopar Therapeutics Inc

0.6678
0.0178 (2.74%)
Apr 24 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Monopar Therapeutics Inc MNPR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0178 2.74% 0.6678 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.68 0.63 0.68 0.657 0.65
more quote information »

Recent News

Date Time Source Heading
4/18/202408:00GLOBEMonopar Announces Radiopharma Presentation Selected for..
4/16/202408:00GLOBEMonopar Announces Filing of Patent Protecting MNPR-101..
4/10/202408:00GLOBEMonopar Initiates Radiopharma Phase 1 Clinical Trial for..
3/28/202407:00GLOBEMonopar Reports Fourth Quarter and Full-Year 2023 Financial..
3/07/202408:30EDGAR2Form 8-K - Current report
3/05/202407:00EDGAR2Form 8-K - Current report
3/05/202407:00GLOBEMonopar Announces Positive Preclinical Therapeutic Isotope..
2/28/202413:45EDGAR2Form 8-K - Current report
2/27/202407:00GLOBEMonopar Provides Update on MNPR-101-Zr Radiopharma Clinical..
2/27/202406:59EDGAR2Form 8-K - Current report
2/22/202407:00EDGAR2Form 8-K - Current report
2/22/202407:00GLOBEMonopar Announces Promising Preclinical Data for its..
2/20/202408:00EDGAR2Form 8-K - Current report
2/20/202408:00GLOBEMonopar Receives Clearance to Proceed with First-in-Human..
1/03/202419:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202419:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/09/202307:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202307:00EDGAR2Form 8-K - Current report
11/09/202307:00GLOBEMonopar Therapeutics Reports Third Quarter 2023 Financial..
11/01/202307:00EDGAR2Form 8-K - Current report
11/01/202307:00GLOBEMonopar Presents Data Showing Tumor Reduction Benefit of..
10/10/202307:00GLOBEMonopar to Participate in the Roth MKM 2023 Healthcare..
10/03/202319:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/03/202319:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/05/202307:00GLOBEMonopar to Participate in the H.C. Wainwright 25th Annual..
8/30/202317:16EDGAR2Form 8-K - Current report
8/10/202307:00EDGAR2Form 8-K - Current report
8/10/202307:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202307:00GLOBEMonopar Therapeutics Reports Second Quarter 2023 Financial..
8/08/202307:00EDGAR2Form 8-K - Current report
8/08/202307:00GLOBEMonopar Provides Encouraging Camsirubicin Clinical Data..
7/11/202307:00EDGAR2Form 8-K - Current report
7/11/202307:00GLOBEMonopar Announces MNPR-101 Radiopharma Collaboration..
7/03/202318:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/03/202318:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/28/202316:13EDGAR2Form 8-K - Current report
6/21/202307:00GLOBEMonopar to Participate in the Radiopharma Forum by the Lake..
6/14/202307:00GLOBEMonopar to Participate in the Maxim Group’s Healthcare..
6/01/202307:00GLOBEMonopar Announces Encouraging Camsirubicin Phase 1b Trial..
5/11/202307:00GLOBEMonopar Therapeutics Reports First Quarter 2023 Financial..

Your Recent History

Delayed Upgrade Clock